PYC Therapeutics
ASX:PYC
$ 1,18
+ $0,06 (5,36%)
1,18 $
+$0,06 (5,36%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,10
Earnings Per Share
$0,04
Revenue Per Share
-228,26%
Operating Margin %
$1,16 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-0,10
Revenue Per Share
$0,04
Operating Margin %
-228,26%
Market Cap
$1,16 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2014 2013 2012 2011 2010
EPS Earnings Per Share $-0,10 $-0,10 $-0,01 $-0,00 $-0,01 $-0,01 $-0,01 $-0,02
Earnings Earnings $-58,33M $-46,66M $-37,33M $-0,00M $-4,67M $-4,67M $-4,05M $-4,72M
RPS Revenue Per Share $0,00 $0,04 $0,05 $0,00 $0,00 $0,00 $0,00 $0,01 $0,00
Revenue Revenue $0,00M $26,17M $22,86M $15,91M $0,70M $0,71M $1,92M $2,36M $0,60M
OCF Operating Cash Flow $0,00M $-51,56M $-38,59M $-24,42M $0,00M $0,00M $0,00M $0,00M $-3,63M
FCF Free Cash Flow $0,00M $-52,54M $-38,90M $-24,91M $0,00M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% -228,26% -176,15% -148,24% 0,00% 0,00% -211,95% -157,63% 0,00%
GM % Gross Margin % 0,00% 100,00% 100,00% 100,00% 0,00% 0,00% -58,58% -28,84% 0,00%
FCFS Free Cash Flow Per Share $0,00 $-0,10 $-0,10 $-0,01 $-0,00 $-0,01 $-0,01 $-0,01 $-0,02
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 583,26M 583,26M 466,61M 3.732,87M 1.002,07M 466,89M 466,89M 405,2M 235,75M
×